FDA Inspection 1266874 — Jiangsu Baozong & Baoda Pharmachem Co., Ltd.
The FDA completed an inspection of Jiangsu Baozong & Baoda Pharmachem Co., Ltd. on Mar 28, 2025 in Nantong. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Veterinary.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 28, 2025
- Fiscal Year
- 2025
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Nantong (China)